MeSH tree: D09.408.051.059
For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival compared with doxorubicin alone, ...
Sep 6, 2024
0
23
There's still much to learn about how doxorubicin, a 50-year-old chemotherapy drug, causes its most concerning side effects. While responsible for saving many lives, this treatment sometimes causes cardiac damage that stiffens ...
Jul 17, 2024
0
53
A research team from the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has made a remarkable discovery that patients with non-alcoholic fatty liver disease (commonly known as fatty ...
Jul 10, 2024
0
50
Researchers probing the next frontiers in cancer therapy have turned to bacteria given their ability to inhibit tumor proliferation by colonizing tumors. Crucially, the Achilles heel of this approach is suboptimal treatment ...
Jul 1, 2024
0
31
Tumors that travel to the lungs, or lung metastases, pose a formidable challenge in the realm of cancer treatment. Conventional chemotherapy often falls short because it's inefficient. It doesn't directly target the lungs ...
Jun 15, 2024
0
94
Cancer is one of the most devastating diagnoses that a person can receive, and it is a society-wide problem. According to the National Cancer Institute, an estimated 2,001,140 new cases of cancer will be diagnosed in the ...
Jun 7, 2024
0
51
In a major advance for the treatment of the deadly brain cancer glioblastoma, Northwestern Medicine scientists have used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy ...
Jun 6, 2024
0
83
Blocking a protein known as CDK7 could prevent heart damage associated with a commonly used cancer chemotherapy medication, according to a study led by scientists at Washington State University. Importantly, the researchers ...
Jun 3, 2024
0
24
Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with a new way to test individual drugs on tumor samples. The results of the clinical study were published ...
Apr 11, 2024
0
64
A new research paper titled "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia" has been published in Oncotarget.
Apr 10, 2024
0
32
